Aster DM Quality Care, a leading integrated healthcare service provider in India, has announced its financial results for the quarter ended 30 June 2026 (Q1 FY26-27).
Revenue for Q1 FY27 grew by 20% YoY to Rs 2,597 crore while operating EBITDA grew by 30% YoY to Rs 576 crore; (excluding Kasargod up by 31% crore). Operating EBITDA margin at 22.2%, increased by 170bps YoY. Excluding the Kasargod operations, EBITDA margin stood at 22.4%, increased by 190bps YoY.
Kasargod Hospital achieved monthly EBITDA break-even within the 9th month of operations. Return on capital employed stood at 22.9%, increased by 246 bps YoY.
Aster DM Healthcare had completed its major merger with Blackstone-backed Quality Care India Limited to form Aster DM Quality Care Limited. This combined entity features 39 hospitals across 28 cities, explicitly highlighting the newly operational Aster MIMS Hospital in Kasaragod as a key regional hub. The merger became effective on July 1, 2026
Commenting on the merger, Dr. Azad Moopen, executive chairman, said, “The coming together of Aster DM Quality Care marks a defining milestone in our nearly four-decade journey of building world-class healthcare institutions. We aspire to create one of India’s leading integrated healthcare platforms, bringing together Aster, CARE, KIMS India, and Evercare into a unified network with over 10,800 beds across 28 cities, positioning Aster Quality Care among the top three hospital chains in India. Over the coming years, we expect to expand this network to more than 15,000 beds.”
As we embark on this new chapter, our philosophy is simple: greater scale, greater clinical excellence, and greater impact. By combining exceptional medical talent with advanced technology, artificial intelligence, robotics, research, and innovation, we will redefine the future of healthcare delivery.
Commenting on the performance for Q1 FY27, Varun Khanna, managing director and Group CEO, said, “The recent merger and formation of Aster DM Quality Care, marks a significant moment for the companies, our patients, our doctors and clinical staff, and for the industry overall. In this new chapter we are committed to keeping our core and value system unchanged, with continued focus on patient care, enabling doctors and hospital operations through technology, and best-in-class clinical outcomes.
Aster DM Quality Care on a combined proforma basis achieved a revenue of Rs 2,597 crore, a growth of 20% YoY, with an EBITDA Margin expansion of +170 bps at 22.2%, on the back of an operating EBITDA increase of 30% to Rs 576 crore. We had the privilege of serving 2 million people in our OP and IP in Q1 FY27, which is 13% more people than in the previous year. Our focus in the coming quarters is on disciplined execution – enhancing patient care, unlocking the full potential of our combined platform, and driving long-term value through operational excellence.”
